Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma.
about
DNA studies using atomic force microscopy: capabilities for measurement of short DNA fragmentsA phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarkerAsparagine synthetase: a new potential biomarker in ovarian cancer.Prognostic biomarkers in ovarian cancer.Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.Presence of neutrophil extracellular traps and citrullinated histone H3 in the bloodstream of critically ill patients.Origin of Circulating Free DNA in Sepsis: Analysis of the CLP Mouse Model.Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats.Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.Differential methylation profile of ovarian cancer in tissues and plasmaAngiogenesis as a strategic target for ovarian cancer therapy.The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.DNA methylation as a universal biomarker.Serum efficacy biomarkers for oncology.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma.Identification of neutrophil extracellular traps in the blood of patients with systemic inflammatory response syndrome.Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients
P2860
Q28080979-DC039B2A-4A8F-4C4C-9D9A-49A14CA9D122Q30414010-2F5856B1-4AFE-4B65-AB02-06C383D49C94Q33790229-746188B0-21A0-4575-BA0D-949853148319Q33894413-78FF9C2F-A5A5-42B2-9AA1-BF854AD39748Q34086636-611D22C0-73A8-45CB-BAA2-34917FCA02ABQ34426839-B17BDD23-9031-418D-A5C0-FDF3376A819FQ34505776-7CF6FAA7-8D1B-4F06-9631-924347A8FBE2Q35931077-8C9B0376-8B66-4BFA-B52A-8F19591E748DQ36037774-CE3B8D61-FEDA-410F-8484-5B10403B415EQ36597182-F1221BD8-10B6-4394-B71A-2AFC3FDEE373Q36865058-7B33DB83-1105-4876-A46F-A6E089DCE50FQ37024691-1854AB31-AE40-4458-8E90-A28FB93C86CEQ37082491-A36F6668-3C8C-4450-8A13-8E54A03FB11CQ37225239-ADB18648-4805-45D6-A5FA-29C4F0A4D113Q37306747-876F58A1-781D-42D0-BF8D-9E6C9F437DACQ37750858-E4480AE1-D3C8-4087-B676-E1E105EB7E4EQ37755150-8B3E4BE7-3EF4-4D42-B5C6-BE284012A7E7Q39149201-F23BAA35-DB4C-4172-BC5A-E5177DAE35A5Q39344296-AF850E8A-8C83-44D4-ABDE-B1583C9625FFQ40978479-6225EA25-0648-42B0-A417-C7ED24773E29Q41006936-6E480AED-3E9A-4762-98CB-5C1187BC4C76Q43274590-137665B3-F021-4464-85CB-135B5D5B62C5Q43484386-B1FB2B73-1635-45AC-9226-051E44E0E850Q55234264-7BB4763B-31BC-4E73-B53C-CAE197E4DEE4Q58702160-C2BF1E1B-AE27-4F3D-ABAD-A223FEF5046A
P2860
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Circulating cell-free DNA: a n ...... therapy in ovarian carcinoma.
@en
type
label
Circulating cell-free DNA: a n ...... therapy in ovarian carcinoma.
@en
prefLabel
Circulating cell-free DNA: a n ...... therapy in ovarian carcinoma.
@en
P2093
P356
P1476
Circulating cell-free DNA: a n ...... therapy in ovarian carcinoma.
@en
P2093
Anil K Sood
Aparna A Kamat
Charles N Landen
Chunhua Lu
David M Gershenson
Dianne Dang
Farideh Z Bischoff
Joe L Simpson
Matthew F Baldwin
P304
P356
10.4161/CBT.5.10.3240
P577
2006-10-26T00:00:00Z